Latest papers

How to follow-up patients with epithelial ovarian cancer.

New advances in ovarian cancer.

Challenges to the paclitaxel/carboplatin algorithm in ovarian cancer treatment.

Ovarian cancer care: it's time for personalized approaches.

Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours.

Increased ERCC1 protein expression is associated with suboptimal debulking in advanced epithelial ovarian cancer.

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Cystic renal tumors: new entities and novel concepts.

Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis.

Immunohistochemical study on an epithelial-myoepithelial intercalated duct carcinoma transplanted to the nude mouse.

Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003.

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.

[Association of functional polymorphisms on MMP-12 and MMP-13 gene promoter region with epithelial ovarian carcinoma].

MUC5AC production is downregulated in NCI-H292 lung cancer cells cultured on type-IV collagen.

Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.

Properties of L-type amino acid transporter 1 in epidermal ovarian cancer.

Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities.

Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature.

Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers

Pap test--with or without vaginal smear?